Ro-3201195

CAS No. 249937-52-8

Ro-3201195( —— )

Catalog No. M36218 CAS No. 249937-52-8

Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 329 In Stock
5MG 304 In Stock
10MG 456 In Stock
25MG 747 In Stock
50MG 1004 In Stock
100MG 1376 In Stock
200MG Get Quote In Stock
500MG 2753 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ro-3201195
  • Note
    Research use only, not for human use.
  • Brief Description
    Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.
  • Description
    Ro-3201195 is a novel orally available p38 MAPK inhibitor with high selectivity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    p38 MAPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    249937-52-8
  • Formula Weight
    371.36
  • Molecular Formula
    C19H18FN3O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NC=1N(N=CC1C(=O)C2=CC(OCC(CO)O)=CC=C2)C3=CC=C(F)C=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • SKLB-163

    SKLB-163 acts by downregulating RhoGDI, activating JNK-1 signaling pathway and caspase-3, and reducing phosphorylated Akt and p44/42 MAPK.

  • VX-745

    A potent and selective p38α kinase inhibitor with IC50 of 9 nM; shows 20-fold selectivity for p38α over p38β (Ki=220 nM) and no significant inhibition for MAP kinases (with the exception of MKK6).

  • TAK-715

    A potent, selective, orally active p38α MAPK inhibitor with IC50 of 7.1 nM.